Kimpel DL - Search Results

1

Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis.

Moosic KB, Olson TL, Freijat M, Khalique S, Hamele CE, Shemo B, Boodoo J, Baker W, Khurana G, Schmachtenberg M, Duffy T, Ratan A, Darrah E, Andrade F, Jones M, Olson KC, Feith DJ, Kimpel DL, Loughran TP Jr. Moosic KB, et al. Among authors: kimpel dl. Front Immunol. 2024 Oct 21;15:1466276. doi: 10.3389/fimmu.2024.1466276. eCollection 2024. Front Immunol. 2024. PMID: 39497832 Free PMC article.

2

Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy.

Kimpel DL, Lewis JE, Gaughan E, Grosh WW, Brenin C. Kimpel DL, et al. J Clin Oncol. 2018 Sep 10;36(26):2743-2744. doi: 10.1200/JCO.2018.79.0428. Epub 2018 Jul 18. J Clin Oncol. 2018. PMID: 30020819 No abstract available.

3

Persistence of Infliximab in Circulation for 7 Years?

Kelting SM, Kimpel DL, Bruns DE. Kelting SM, et al. Among authors: kimpel dl. Clin Chem. 2015 Nov;61(11):1420-1. doi: 10.1373/clinchem.2015.242024. Clin Chem. 2015. PMID: 26511353 No abstract available.

4

Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysis.

Baker MG, Cresce ND, Ameri M, Martin AA, Patterson JW, Kimpel DL. Baker MG, et al. Among authors: kimpel dl. J Clin Rheumatol. 2014 Apr;20(3):167-71. doi: 10.1097/RHU.0000000000000088. J Clin Rheumatol. 2014. PMID: 24662561

5

Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

Richardson CL, Delehanty LL, Bullock GC, Rival CM, Tung KS, Kimpel DL, Gardenghi S, Rivella S, Goldfarb AN. Richardson CL, et al. Among authors: kimpel dl. J Clin Invest. 2013 Aug;123(8):3614-23. doi: 10.1172/JCI68487. Epub 2013 Jul 25. J Clin Invest. 2013. PMID: 23863711 Free PMC article.

6

Contrast-enhanced magnetic resonance imaging positively impacts the management of some patients with rheumatoid arthritis or suspected RA.

Fox MG, Stephens T, Jarjour WN, Anderson MW, Kimpel DL. Fox MG, et al. Among authors: kimpel dl. J Clin Rheumatol. 2012 Jan;18(1):15-22. doi: 10.1097/RHU.0b013e31823e5ab3. J Clin Rheumatol. 2012. PMID: 22157267

7

Catching a break.

Tubb A, Liokis E, Alford B, Kimpel DL. Tubb A, et al. Among authors: kimpel dl. Am J Med. 2008 May;121(5):395-8. doi: 10.1016/j.amjmed.2007.11.009. Am J Med. 2008. PMID: 18456035 No abstract available.

8

Clinical implication of autoantibodies in patients with systemic rheumatic diseases.

Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH. Satoh M, et al. Among authors: kimpel dl. Expert Rev Clin Immunol. 2007 Sep;3(5):721-38. doi: 10.1586/1744666X.3.5.721. Expert Rev Clin Immunol. 2007. PMID: 20477023

9

Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome.

Hsiao GR, Wolf RE, Kimpel DL. Hsiao GR, et al. Among authors: kimpel dl. J Clin Rheumatol. 2001 Oct;7(5):336-9. doi: 10.1097/00124743-200110000-00017. J Clin Rheumatol. 2001. PMID: 17039166

10

CD5 (OKT1) augments CD3-mediated intracellular signaling events in human T lymphocytes.

Berney SM, Schaan T, Wolf RE, Kimpel DL, van der Heyde H, Atkinson TP. Berney SM, et al. Among authors: kimpel dl. Inflammation. 2001 Aug;25(4):215-21. doi: 10.1023/a:1010919719200. Inflammation. 2001. PMID: 11580097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters